Status:
UNKNOWN
Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)
Lead Sponsor:
Zurita Laboratorio Farmaceutico Ltda.
Conditions:
Treatment of Acne Vulgaris Grade II in a Short Period of Time.
Eligibility:
All Genders
12-35 years
Phase:
PHASE4
Brief Summary
Sixty two subjects will take part in this study. The study is unic arm. The subjects used the product once and will be evaluated in the regression of pimples in the times 0,4,6,8 and 24 hours after ap...
Eligibility Criteria
Inclusion
- Subjects of both sexes aged to 12 years to 35 years
- Oily skin prone to acne
- Presence of at least three inflammatory lesions, diagnosed as grade II acne vulgaris.
- Sign the informed Consent Form
- Comply the requirements and attend to study visits
Exclusion
- Pregnancy (need for urinary pregnancy test for women of childbearing age)
- Lactation
- Presence of acne conglobata and nodulocystic
- Pathologies associated hormonal (thyroid diseases, ovaries micropolycystic)
- Drug use systemic corticosteroids, anticonvulsants and / or new drugs for up to one month before to selection.
- History of atopy or allergic cutaneous
- History of hypersensitivity to benzoyl peroxide and sulfur
- Beginning or ending the use of contraceptives (for females)
- Intense sun exposure until one month before the evaluation
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01260571
Start Date
January 1 2011
End Date
March 1 2011
Last Update
December 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medcin Instituto da Pele
Osasco, São Paulo, Brazil, 06023-000